Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FBDIX vs. SHPAX: which is better?

Bottom line

FBDIX vs SHPAX: the short answer

FBDIX (Franklin Biotechnology Discovery Fund) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 19% of their top holdings (by weight) are shared.

But FBDIX is far broader, holding 126 positions to 29 for SHPAX, so beyond the top names it adds exposure SHPAX doesn't have.

FBDIX is cheaper at 1.01% vs 3% — a difference of $199 a year per $10,000 invested.

Over five years, FBDIX returned +5.0% a year vs +3.1% for SHPAX (reporting dates differ).

Updated Nov 19, 2026

FBDIX vs SHPAX side by side

FBDIXSHPAX
TypeMutual fundMutual fund
Fund familyFranklin TempletonSaratoga Advantage
CategoryTechnology SectorTechnology Sector
Expense ratio1.01%3%
Annual cost per $10k$101$300
10-yr cost on $10k (prospectus)$1,728$3,702
Max front load5.5%5.75%
12b-1 fee0.25%—
1-yr return+43.9%−5.5%
5-yr return (annualized)+5.0%+3.1%
10-yr return (annualized)+6.4%+4.1%
Best quarter+29.5%+15.0%
Worst quarter−24.5%−13.0%
Net assets (fund)$1.2B$10.5M
Number of holdings12629
Portfolio turnover38%22%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFBDIXSHPAXDifference
2024+4.0%+0.3%+3.7%
2023+18.4%−0.4%+18.8%
2022−12.7%+2.0%−14.7%
2021−17.7%+16.7%−34.4%
2020+29.9%+3.6%+26.3%
2019+34.8%+16.2%+18.7%
2018−15.7%−5.5%−10.3%
2017+18.8%+12.0%+6.9%
2016−17.2%−2.0%−15.2%
2015+5.5%+6.9%−1.4%

Source: Fund prospectus bar charts

Holdings overlap

5 of FBDIX's top 25 holdings also appear in SHPAX's top 25.

Shared top holdings
HoldingFBDIXSHPAX
Amgen, Inc.4.39%5.04%
Gilead Sciences, Inc.3.86%3.94%
Regeneron Pharmaceuticals, Inc.3.77%3.93%
Vertex Pharmaceuticals, Inc.3.54%3.36%
Eli Lilly & Co.1.31%2.11%

Source: SEC Form N-PORT

FBDIX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

SHPAX top 10

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. United Therapeutics Corp — 6.17%
  4. Amgen Inc — 5.04%
  5. Mckesson Corp — 4.90%
  6. Lantheus Holdings Inc — 4.64%
  7. Exelixis Inc — 4.55%
  8. Novartis Ag — 4.50%
  9. Cencora Inc — 4.33%
  10. Gilead Sciences Inc — 3.94%

FAQ

What is the difference between FBDIX and SHPAX?
FBDIX (Franklin Biotechnology Discovery Fund) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 19% of their top holdings (by weight) are shared. But FBDIX is far broader, holding 126 positions to 29 for SHPAX, so beyond the top names it adds exposure SHPAX doesn't have.
Which is cheaper, FBDIX or SHPAX?
FBDIX has the lower expense ratio (1.01%).
Should I own both FBDIX and SHPAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.